• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Medicover

214.00 SEK

+1.42 %

Less than 1K followers

MCOV B

NASDAQ Stockholm

Health Care Providers

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.42 %
+6.20 %
+3.38 %
-2.95 %
-3.39 %
-10.83 %
+26.70 %
-13.71 %
+226.72 %

Medicover operates in the healthcare industry. The company is an international healthcare and diagnostics company and focuses on providing medical services and laboratory analyses. The company's services are aimed at individuals and companies that need fast and accessible care. Medicover was founded in 1994 and is headquartered in Stockholm, Sweden.

Read more
Market cap
32.86B SEK
Turnover
12.14M SEK
Revenue
25.69B
EBIT %
6.55 %
P/E
38.54
Dividend yield-%
1.01 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
22/7
2026

Interim report Q2'26

4/11
2026

Interim report Q3'26

Press release5/5/2026, 11:30 AM

Medicover har tecknat ett revolverande kreditfacilitetsavtal på 450 MEUR

Medicover
Press release5/5/2026, 11:30 AM

Medicover signs a EUR 450 million revolving credit facility

Medicover
Third party research4/30/2026, 4:57 AM

Medicover: Stronger than the weather - ABG

* Strong Q1 beat with 110bps margin expansion on adj. EBITDA * Adj. EBITDA up 1% for '26e-'28e on Q1 beat * FVR unchanged at SEK 190-270 on minor estimate revisions A solid start to '26 despite weather drag Q1 was 8%/6% above ABGSCe/Infront consensus...

Medicover

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/29/2026, 1:15 PM

Kommuniké från årsstämma i Medicover AB (publ)

Medicover
Regulatory press release4/29/2026, 1:15 PM

Bulletin from annual general meeting in Medicover AB (publ)

Medicover
Medicover, Audiocast, Q1'26
Webcast4/29/2026, 7:30 AM

Medicover, Audiocast, Q1'26

Medicover
Third party research4/29/2026, 7:18 AM

Medicover: Model proves itself in Q1 - ABG

* 8%/6% adj. EBITDA vs ABGSCe/Infront cons in Q1 * Cons estimates likely up 1-3% on adj. EBITDA '26e * Model proved itself despite the weather headwind we flagged Q1 results Medicover reported a strong start to '26 with sales in-line vs cons and a clear...

Medicover
Regulatory press release4/29/2026, 5:45 AM

Delårsrapport januari-mars 2026

Medicover
Regulatory press release4/29/2026, 5:45 AM

Interim report January-March 2026

Medicover
Press release4/16/2026, 8:00 AM

Inbjudan till presentation av Medicovers rapport för första kvartalet 2026

Medicover
Press release4/16/2026, 8:00 AM

Invitation to Medicover’s results presentation for Q1 2026

Medicover
Third party research4/2/2026, 5:22 AM

Medicover: Weather is set to be a drag - ABG

* Q1'26 numbers due on 29 April at 07:45 CET * Near-term caution, but the model should continue to prove itself * Fair value range down to SEK 190-270 (200-280) Q1'26 should be marked by cold weather We expect colder-than-usual temperatures and severe...

Medicover
Press release3/31/2026, 1:00 PM

Medicovers Social finance investor report är publicerad

Medicover
Press release3/31/2026, 1:00 PM

Medicover’s Social finance investor report is now published

Medicover
Regulatory press release3/30/2026, 9:00 AM

Medicover AB (publ) publicerar årsredovisningen för 2025

Medicover
Regulatory press release3/30/2026, 9:00 AM

Medicover AB (publ) publishes Annual report for 2025

Medicover
Regulatory press release3/26/2026, 4:20 PM

Kallelse till årsstämma i Medicover AB (publ)

Medicover
Regulatory press release3/26/2026, 4:20 PM

Notice of annual general meeting of Medicover AB (publ)

Medicover
Third party research3/9/2026, 6:42 AM

Medicover: From build-out to fill-up - ABG

* Focus on sport/wellness, dental and smaller centres * Adj. EBITDAaL margin expansion: 11.7% to 12.9% during '26e-'28e * ~25% below its historical average on NTM EV/EBITDA Polish capex skewing to margin-accretive growth levers Last Wednesday we visited...

Medicover
Third party research2/12/2026, 6:29 AM

Medicover: Path to 2028 explained - ABG

* Expanding margins on the back of a maturing asset base * A clear and differentiated strategy for each of the four core markets * Join us for our 4 March site visit in Warsaw (RSVP link below) From expansion to utilisation and margin delivery The key...

Medicover